跳至主要内容
临床试验/NCT05472012
NCT05472012已完成不适用

Performance of Masimo INVSENSOR00057 in Detecting Atrial Fibrillation (Afib)

Masimo Corporation2 个研究点 分布在 1 个国家目标入组 139 人开始时间: 2022年7月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
139
试验地点
2
主要终点
Sensitivity of INVSENSOR00057 Atrial Fibrillation (Afib) Detection Function

研究概览

简要总结

This study is designed to validate the performance of Masimo INVSENSOR00057 in detecting atrial fibrillation. The noninvasive ECG measurements will be compared to results obtained from an FDA-cleared ECG monitor.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is 18 years of age or older.
  • Subject is confirmed to have active atrial fibrillation at the time of enrollment.

排除标准

  • Subject is confirmed to have concurrent active arrhythmias (e.g., PVCs, bradycardia, etc.) at the time of enrollment.
  • Subject is allergic to adhesives or ECG gel.
  • Subject whose skin is not intact in or at the vicinity of the device placement site.

结局指标

主要结局

Sensitivity of INVSENSOR00057 Atrial Fibrillation (Afib) Detection Function

时间窗: 1-5 hours

Afib detection accuracy will be determined by analyzing the sensitivity of INVSENSOR00057 Afib detection function when compared to data collected using a FDA-cleared ECG monitor.

Specificity of INVSENSOR00057 Atrial Fibrillation (Afib) Detection Function

时间窗: 1-5 hours

Afib detection accuracy will be determined by analyzing the specificity of INVSENSOR00057 Afib detection function when compared to data collected using a FDA-cleared ECG monitor.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验